Uranium Energy’s ‘Produce and Hoard’ Strategy: Costs Spike, Sales Stay at Zero, but $794 Million War Chest Shores Up the Story

Uranium Energy Corp begins Burke Hollow production; Q3 miss (no revenue, wider loss); stock down 27%. Company stockpiles uranium; analysts maintain buy.

Uranium Energy Corp has kicked off production at its Burke Hollow project in Texas — the largest new US uranium development of its kind in more than a decade — yet the milestone did nothing to shield the stock from a brutal selloff. The company’s fiscal third-quarter report showed no revenue, a wider-than-expected loss, and production costs that ran well above plan, sending shares down 27% over the past month and 45% from their 52-week high of €17.34. The stock now trades at €9.54.

The decision to forgo all sales is deliberate. Management is stockpiling output in a bet that spot uranium prices, currently at $86.10 per pound, will rebound later this year or in early 2027. That unhedged strategy means any uptick in the market flows directly to realised revenue — but in the meantime, the income statement is bare. The third-quarter loss came in at $0.11 per share, more than triple the $0.03 deficit analysts had expected.

Production at Burke Hollow yielded roughly 32,000 pounds of uranium concentrate during the quarter. Direct costs came to $46.69 per pound, but delays in regulatory approvals for new header houses at Christensen Ranch and Burke Hollow pushed total costs to $54.61 per pound. The company expects those bottlenecks to clear in the current fourth quarter, with the new facilities operating for a full three months and driving unit costs sharply lower.

Despite the earnings miss, Wall Street analysts are standing their ground. HC Wainwright, Roth MKM and Goldman Sachs all maintain buy ratings. The targets vary widely — $26.75, $17.00 and $16.00 respectively — but each implies substantial upside from the current share price. HC Wainwright did trim its full-year 2026 loss forecast to $0.14 per share from $0.09, yet kept its positive view on liquidity.

And liquidity is the company’s strongest card. Uranium Energy holds $488 million in cash and has no debt. On top of that, total liquid assets amount to $794 million, and the 1.46 million pounds of uranium stored in inventory is worth around $127 million at current market prices. That war chest gives management the room to sit on unsold output while waiting for better pricing — a luxury most producers cannot afford.

Beyond the near-term production ramp, the company is laying groundwork for a longer-term transformation into an integrated nuclear fuel supplier. United States Uranium Refining & Conversion Corp (UR&C) has received the first licensing milestone number from the US Nuclear Regulatory Commission for a planned conversion facility. Fluor Corporation is leading engineering work, and a site selection process is underway in coordination with the US Department of Energy. A Class IV cost study is due by mid-2027, with revenue from the conversion plant not expected before then. The next ISR production start, at the Ludeman site, is also pencilled in for 2027.

The broader uranium market remains sluggish. Spot activity is muted as utilities refrain from buying, though RBC Capital notes early positive signals from a recent industry conference. Analysts expect the market to tighten in late 2026 or early 2027, once utility inventories built during the 2019–2023 contracting cycle are exhausted. For Uranium Energy, the timing of that recovery will determine whether its bet on stockpiling pays off — or whether the zero-revenue quarters keep piling up. With a relative strength index of 40.1, the stock is approaching oversold territory, but closing the roughly 20% gap to its 50-day moving average will depend on how quickly production costs actually fall in the fourth quarter.